Macroaxis: Personalized Investing
Personalized Investing and
Digital Wealth Optimization

ABT MDT SYK ISRG Processed Foods Energy Outsourcing Hybrid Mix 
Benchmark SP 500  1,650   2.19  Index Moved Down -0.13% United States ...


Processing
Collecting data for SYK

Stryker valuation

 
 Companies |  Insiders  | Dashboard  
     

Stryker

Stock@New York Stock Exchange 
United States USD
      
Stryker has current Real Value of $79.55 per share. The regular price of the company is $67.4. At this time the company appears to be under valued. Macroaxis measures value of Stryker from inspecting the company fundamentals such as Operating Margin of 20.62%, Shares Outstanding of 378.06M and Return On Equity of 15.20% as well as reviewing its technical indicators and Probability Of Bankruptcy. In general, we recommend to buy undervalued stocks and to dispose of overvalued stocks since at some point securites prices and their ongoing real values will draw towards each other.
change horizon
Investment horizon: 
  30 Days    Login   to change

Stryker Total Value Analsys

Stryker Corporation is at this time estimated to have company total value of 24.33 B with market capitalization of 25.59 B, debt of 2.77 B, and cash on hands of 4.49 B. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Stryker fundamentals before making security assessment based on the enterprise value of the company
Takeover PriceMarket CapDebt ObligationsCash
24.33 B25.59 B2.77 B4.49 B

Stryker Investor Information

About 19.0% of the company outstanding shares are owned by corporate insiders. Book value of Stryker Corporation was at this time as 22.37. The company has Price/Earnings To Growth (PEG) ratio of 1.9. Stryker Corporation last dividend was issued on June 26, 2013. This company had 2:1 split on May 17, 2004. Stryker Corporationration, a medical technology company, offer reconstructive, medical and surgical, and neurotechnology and spine solutions for doctors, hospitals, and other healthcare facilities. To find out more about STRYKER CP contact Curt Hartman at 269-385-2600 or learn more at http://www.strykercorp.com.

Stryker Asset Utilization

Stryker exercises its assets roughly 8.43 %, realizing $0.08 for each dollar of assets held by the company. A flourishing assets utilization indicates the company is being more effective with each dollar of assets it has. In other words assets utilization of Stryker shows how effective it operates for each dollar spent on its assets

Stryker Ownership Allocation (%)

Stryker shows a total of three hundred seventy-eight million sixty thousand outstanding shares. Over half of Stryker outstanding shares are owned by other institutions. These other institutions are typically referred to corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulation than regular investors in Stryker. Please watch out for any change in the institutional holdings of Stryker as this could mean something significant has changed or about to change at the company. Please note that no matter how much assets the company owns, if the real value of the the company is less than the current market value, you may not be able to make money on it.

Stryker Profitability Analysis

The company reported last year revenue of 8.69 B. Total Income to common stockholders was 1.25 B with profit before taxes, overhead, and interest of 5.88 B.

Stryker Debt Analysis

STRYKER CP has about 4.49 B in cash with 1.86 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 11.87.
The company has 2.77 B in debt with debt to equity (D/E) ratio of 0.33 which is OK given its current industry classification. Stryker Corporation has Current Ratio of 4.57 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.
June 19, 2013
67.4
Stryker Market Value
Under Valued
Downside
60.66
79.55
Real Value
82.88
Upside
Stryker is relatively not risky asset. Calculation of real value of Stryker is based on 1 month time horizon. Increasing Stryker time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Stryker Market Share

Stryker Corporation is rated fourth in market capitalization category among related companies. Market capitalization of Medical Appliances and Equipment industry is at this time estimated at about 245.63 Billion. Stryker retains roughly 25.59 Billion in market capitalization claiming about 10% of all equities under Medical Appliances and Equipment industry.
Follow Stryker Valuation with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Stryker to your reader
 

Stryker Revenue

Based on latest financial disclosure Stryker Corporation reported 8.69 B of revenue. This is 84.79% higher than that of Healthcare sector, and 371.92% higher than that of Medical Appliances and Equipment industry, The Revenue for all stocks is 6.54% lower than the firm.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium